• ABO Group and Rh Typing
  • ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
  • Apolipoprotein L1 (APOL1) Genotyping for Chronic Kidney Diseases
  • Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • SMAD4 Germline Mutation Analysis
  • Lymphocyte proliferation panel, Blood
  • Galactosemia
  • Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Blood
  • Hepatitis D Virus (HDV) Antibody, Total
  • Dihydrocodeine, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Histoplasma capsulatum Nucleic Acid Detection, Molecular Method
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Histoplasma capsulatum Nucleic Acid Detection, Molecular Method
Medical Test

Turnaround Time
Access to Histoplasma capsulatum Nucleic Acid Detection, Molecular Method is restricted.